Loading...
Loading...
A clinical decision rule designed to identify women with unprovoked VTE who have a sufficiently low recurrence risk to safely discontinue anticoagulation after completing the minimum treatment period. HERDOO2 was developed in the REVERSE study to overcome the limitation that most VTE recurrence risk scores perform best in men — women with first unprovoked VTE have overall lower recurrence rates than men.
Awaiting input
Fill in the parameters to see your result